EG20466A - Process for preparing of acylaminoindole derivatives - Google Patents

Process for preparing of acylaminoindole derivatives

Info

Publication number
EG20466A
EG20466A EG21493A EG21493A EG20466A EG 20466 A EG20466 A EG 20466A EG 21493 A EG21493 A EG 21493A EG 21493 A EG21493 A EG 21493A EG 20466 A EG20466 A EG 20466A
Authority
EG
Egypt
Prior art keywords
aryl
alkyl
alkylaryl
hydrogen
pct
Prior art date
Application number
EG21493A
Other languages
English (en)
Inventor
John A Macor
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG20466A publication Critical patent/EG20466A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Soft Magnetic Materials (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyrrole Compounds (AREA)
EG21493A 1992-04-10 1993-04-07 Process for preparing of acylaminoindole derivatives EG20466A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86638292A 1992-04-10 1992-04-10

Publications (1)

Publication Number Publication Date
EG20466A true EG20466A (en) 1999-05-31

Family

ID=25347493

Family Applications (1)

Application Number Title Priority Date Filing Date
EG21493A EG20466A (en) 1992-04-10 1993-04-07 Process for preparing of acylaminoindole derivatives

Country Status (31)

Country Link
US (1) US5498626A (xx)
EP (1) EP0635015B1 (xx)
JP (1) JP2544704B2 (xx)
KR (1) KR0179074B1 (xx)
CN (1) CN1038506C (xx)
AT (1) ATE148465T1 (xx)
AU (1) AU670270B2 (xx)
BR (1) BR9306221A (xx)
CA (1) CA2132706C (xx)
CZ (1) CZ282653B6 (xx)
DE (1) DE69307875T2 (xx)
DK (1) DK0635015T3 (xx)
EG (1) EG20466A (xx)
ES (1) ES2097496T3 (xx)
FI (2) FI111256B (xx)
GR (1) GR3022767T3 (xx)
HR (1) HRP930753B1 (xx)
HU (1) HUT64060A (xx)
IL (1) IL105309A0 (xx)
MX (1) MX9301996A (xx)
MY (1) MY115278A (xx)
NO (1) NO309860B1 (xx)
NZ (1) NZ251047A (xx)
PL (1) PL172232B1 (xx)
RU (1) RU2110516C1 (xx)
SK (1) SK278182B6 (xx)
TW (1) TW394769B (xx)
UA (1) UA34452C2 (xx)
WO (1) WO1993021180A1 (xx)
YU (1) YU48916B (xx)
ZA (1) ZA932536B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
JP2644088B2 (ja) 1992-04-07 1997-08-25 フアイザー・インコーポレイテツド ５−ｈｔ１作動薬としてのインドール誘導体
ES2070772B1 (es) * 1993-08-09 1996-02-16 Pfizer Derivados de acilaminoindol
AU686654B2 (en) * 1993-08-31 1998-02-12 Pfizer Inc. 5-arylindole derivatives
GB9402011D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
GB9402016D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
US5965582A (en) * 1994-08-03 1999-10-12 Asta Medica Aktiengesellschaft N-benzylindole and benzopyrazole derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunemodulating effect
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420503D0 (en) * 1994-10-11 1994-11-23 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
AU3170099A (en) * 1998-04-16 1999-11-08 Yamanouchi Pharmaceutical Co., Ltd. Remedies for obesity
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
EP1594490A4 (en) * 2003-01-22 2006-03-22 Gtx Inc TREATMENT OF WOMEN ANDROGEN DISEASE ASSOCIATED DISORDERS (ADIF) USING ANDROGENIC RECEPTOR MODULATORS (SARM)
AU2008332880C1 (en) * 2007-12-07 2012-07-19 Pfizer Inc. Tosylate salt of trans-N-isobutyl-3-fluoro-3- [3-fluoro-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
CN103408535B (zh) * 2013-08-13 2016-03-02 张家港威胜生物医药有限公司 一种依来曲普坦中间体-5-溴-3-(n-甲基吡咯啉-2-基甲基)-1h-吲哚合成工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
NZ197998A (en) * 1980-08-12 1985-08-16 Glaxo Group Ltd 5-amino(methyl)-1h-indol-3-ylalkaneamines
BE889931A (fr) * 1980-08-12 1982-02-11 Glaxo Group Ltd Derives indoliques, leur preparation et leurs applications en tant que medicaments
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
NZ238424A (en) * 1990-06-07 1993-12-23 Wellcome Found 3,5-substituted indole derivatives; medicaments and preparatory processes.
HUT64326A (en) * 1990-10-15 1993-12-28 Pfizer Process for production indole derivatives and pharmaceutical preparations containing these compounds
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
KR0184911B1 (ko) * 1991-11-25 1999-05-01 알렌 제이. 스피겔 인돌유도체

Also Published As

Publication number Publication date
FI111256B (fi) 2003-06-30
AU670270B2 (en) 1996-07-11
MX9301996A (es) 1994-03-31
HU9301048D0 (en) 1993-06-28
NO309860B1 (no) 2001-04-09
CZ282653B6 (cs) 1997-08-13
JPH07501831A (ja) 1995-02-23
YU48916B (sh) 2002-11-15
HRP930753A2 (en) 1994-10-31
CA2132706C (en) 1998-08-04
CA2132706A1 (en) 1993-10-28
CN1080288A (zh) 1994-01-05
BR9306221A (pt) 1998-06-30
IL105309A0 (en) 1993-08-18
WO1993021180A1 (en) 1993-10-28
EP0635015B1 (en) 1997-01-29
US5498626A (en) 1996-03-12
NO943803D0 (no) 1994-10-07
EP0635015A1 (en) 1995-01-25
CN1038506C (zh) 1998-05-27
SK278182B6 (en) 1996-03-06
DE69307875T2 (de) 1997-05-22
ZA932536B (en) 1994-10-08
FI20010214A (fi) 2001-02-05
YU25593A (sh) 1996-10-09
NZ251047A (en) 1996-09-25
DE69307875D1 (de) 1997-03-13
GR3022767T3 (en) 1997-06-30
FI931613A0 (fi) 1993-04-08
JP2544704B2 (ja) 1996-10-16
RU2110516C1 (ru) 1998-05-10
KR0179074B1 (ko) 1999-03-20
ES2097496T3 (es) 1997-04-01
CZ247794A3 (en) 1995-07-12
SK120794A3 (en) 1995-05-10
KR950700903A (ko) 1995-02-20
UA34452C2 (uk) 2001-03-15
AU3782193A (en) 1993-11-18
DK0635015T3 (da) 1997-03-17
RU94045902A (ru) 1996-08-27
FI931613A (fi) 1993-10-11
MY115278A (en) 2003-05-31
ATE148465T1 (de) 1997-02-15
PL172232B1 (pl) 1997-08-29
HUT64060A (en) 1993-11-29
HRP930753B1 (en) 2000-10-31
NO943803L (no) 1994-10-07
TW394769B (en) 2000-06-21

Similar Documents

Publication Publication Date Title
EG20466A (en) Process for preparing of acylaminoindole derivatives
MY111683A (en) Indole derivatives.
MY108909A (en) Indole derivatives
EG21209A (en) Indole derivatives
EG20547A (en) Process for preparing of 5 arylindole derivatives and their use to pharmaceutical composition
EG20416A (en) Process for preparing of indole derivatives and their use in treating migraine